Status:
COMPLETED
Earlier Intraocular Pressure Control After Ahmed Glaucoma Valve Implantation for Glaucoma
Lead Sponsor:
University of California, Los Angeles
Conditions:
Glaucoma
Eligibility:
All Genders
18-85 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to compare the occurrence rate of the high pressure phase and the final pressure outcomes between patients treated with glaucoma medication prior to the expected onset of ...
Detailed Description
Tube shunt procedures are a popular surgery for the control of glaucoma. Tube shunt devices are designed to drain eye fluid (aqueous humor) through a tube inserted into the front chamber of the eye (a...
Eligibility Criteria
Inclusion
- Patients requiring Ahmed glaucoma valve implantation to control intraocular pressure between the ages of 18 and 85 years.
Exclusion
- Unwilling or unable to give consent or unwilling to accept randomization.
- Patient out of area and potentially unavailable for follow-up visits.
- Known allergic reaction to timolol, brimonidine, dorzolamide, brinzolamide, or sulfa drugs.
- Known medical contraindications to the use of beta-blockers, including congestive heart failure, heart block, asthma, and chronic obstructive pulmonary disease.
- Concurrent intraocular procedure with Ahmed glaucoma valve implantation
- Previous Ahmed glaucoma valve implantation
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT00869141
Start Date
March 1 2009
End Date
March 1 2013
Last Update
December 30 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Juels Stein Eye Institute
Los Angeles, California, United States, 90095